Literature DB >> 17565992

Phosphorylation of the delta-opioid receptor regulates its beta-arrestins selectivity and subsequent receptor internalization and adenylyl cyclase desensitization.

Yu Qiu1, Horace H Loh, Ping-Yee Law.   

Abstract

In the current study, we investigated the role of receptor phosphorylation and beta-arrestins in delta-opioid receptor (DOR) signaling and trafficking by using a DOR mutant in which all Ser/Thr residues in the C terminus were mutated to Ala (DTS). We demonstrated that the DOR agonist D-[Pen(2),Pen(5)]enkephalin could induce receptor internalization and adenylyl cyclase (AC) desensitization of DTS, but with comparatively slower kinetics than those observed with wild type DOR. Blockade of the internalization of DTS by the dominant-negative mutant dynamin, dynamin K44E, did not affect AC desensitization. However, depletion of beta-arrestins almost totally blocked both internalization and AC desensitization of DTS. A BRET assay suggested that DOR phosphorylation promotes receptor selectivity for beta-arrestin 2 over beta-arrestin 1. Furthermore, in mouse embryonic fibroblast (MEF) cells lacking either beta-arrestin 1 (beta arr1(-/-)) or beta-arrestin 2 (beta arr2(-/-)), agonist-induced DTS desensitization and internalization were similar to that observed in wild type MEFs. In contrast, although DOR internalization decreased in both beta arr1(-/-) MEFs and beta arr2(-/-) MEFs, DPDPE-induced DOR desensitization was significantly reduced in beta arr2(-/-) MEFs, but not in beta arr1(-/-) MEFs. Additionally, the BRET assay suggested that depletion of phosphorylation did not influence the stability of the receptor-beta-arrestin complex. Consistent with this observation, DTS did not recycle after internalization, which is like wild type DOR. Taken together, these results indicate that receptor phosphorylation confers DOR selectivity for beta-arrestin 2 without affecting the stability of the receptor-beta-arrestin complex and the fate of the internalized receptor.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17565992     DOI: 10.1074/jbc.M611258200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  Ligand- and cell-dependent determinants of internalization and cAMP modulation by delta opioid receptor (DOR) agonists.

Authors:  Iness Charfi; Karim Nagi; Ouissame Mnie-Filali; Dominic Thibault; Gianfranco Balboni; Peter W Schiller; Louis-Eric Trudeau; Graciela Pineyro
Journal:  Cell Mol Life Sci       Date:  2014-04       Impact factor: 9.261

Review 2.  Opioid-receptor-heteromer-specific trafficking and pharmacology.

Authors:  Richard M van Rijn; Jennifer L Whistler; Maria Waldhoer
Journal:  Curr Opin Pharmacol       Date:  2009-10-19       Impact factor: 5.547

3.  The δ-opioid receptor positive allosteric modulator BMS 986187 is a G-protein-biased allosteric agonist.

Authors:  M Alexander Stanczyk; Kathryn E Livingston; Louise Chang; Zara Y Weinberg; Manojkumar A Puthenveedu; John R Traynor
Journal:  Br J Pharmacol       Date:  2019-04-14       Impact factor: 8.739

Review 4.  Optical approaches for single-cell and subcellular analysis of GPCR-G protein signaling.

Authors:  Dinesh Kankanamge; Kasun Ratnayake; Kanishka Senarath; Mithila Tennakoon; Elise Harmon; Ajith Karunarathne
Journal:  Anal Bioanal Chem       Date:  2019-03-30       Impact factor: 4.142

Review 5.  Molecular Pharmacology of δ-Opioid Receptors.

Authors:  Louis Gendron; Catherine M Cahill; Mark von Zastrow; Peter W Schiller; Graciela Pineyro
Journal:  Pharmacol Rev       Date:  2016-07       Impact factor: 25.468

6.  Tolerance to high-internalizing δ opioid receptor agonist is critically mediated by arrestin 2.

Authors:  Ana Vicente-Sanchez; Isaac J Dripps; Alycia F Tipton; Heba Akbari; Areeb Akbari; Emily M Jutkiewicz; Amynah A Pradhan
Journal:  Br J Pharmacol       Date:  2018-06-07       Impact factor: 8.739

7.  δ-Opioid mechanisms for ADL5747 and ADL5859 effects in mice: analgesia, locomotion, and receptor internalization.

Authors:  Chihiro Nozaki; Bertrand Le Bourdonnec; David Reiss; Rolf T Windh; Patrick J Little; Roland E Dolle; Brigitte L Kieffer; Claire Gavériaux-Ruff
Journal:  J Pharmacol Exp Ther       Date:  2012-06-13       Impact factor: 4.030

8.  ßarrestin1-biased agonism at human δ-opioid receptor by peptidic and alkaloid ligands.

Authors:  Benjamin Aguila; Laurent Coulbault; Audrey Davis; Nicolas Marie; Ahmed Hasbi; Florian Le bras; Géza Tóth; Anna Borsodi; Vsevolod V Gurevich; Philippe Jauzac; Stéphane Allouche
Journal:  Cell Signal       Date:  2011-11-09       Impact factor: 4.315

Review 9.  The delta opioid receptor tool box.

Authors:  Ana Vicente-Sanchez; Laura Segura; Amynah A Pradhan
Journal:  Neuroscience       Date:  2016-06-24       Impact factor: 3.590

10.  Select G-protein-coupled receptors modulate agonist-induced signaling via a ROCK, LIMK, and β-arrestin 1 pathway.

Authors:  Nitish Mittal; Kristofer Roberts; Katsuri Pal; Laurent A Bentolila; Elissa Fultz; Ani Minasyan; Catherine Cahill; Amynah Pradhan; David Conner; Kathryn DeFea; Christopher Evans; Wendy Walwyn
Journal:  Cell Rep       Date:  2013-11-14       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.